• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: C.R. BARD, INC. (BASD) -3006260740 TITANIUM DOME IMPLANTABLE PORT, GROSHONG SINGLE-LUMEN, 8F; PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

C.R. BARD, INC. (BASD) -3006260740 TITANIUM DOME IMPLANTABLE PORT, GROSHONG SINGLE-LUMEN, 8F; PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR Back to Search Results
Model Number 0602850
Medical Device Problem Codes Fracture (1260); Material Separation (1562); Migration (4003)
Health Effect - Clinical Codes Foreign Body In Patient (2687); Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available (4581)
Date of Event 11/02/2022
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that fifteen years eight months and ten days post port placement, the part of the catheter allegedly fractured and separated.It was further reported that upon x-ray imaging, the catheter allegedly migrated to the heart.Reportedly, the remnant fragment was still inside the patient.The current status of the patient is unknown.
 
Additional Manufacturer Narrative
As the lot number for the device was provided, a review of the device history record is currently being performed.The return of the sample is pending.The investigation of the reported event is currently underway.(expiry date: 08/2011).
 
Additional Manufacturer Narrative
H10: manufacturing review: the device history records have been reviewed and this lot met all release criteria.There was nothing found to indicate there was a manufacturing related cause for this event.Investigation summary: one titanium implantable port attached to a groshong catheter in two segments were returned for evaluation.Gross visual, microscopic visual, tactile and functional evaluations were performed on the returned device.The investigation is confirmed for the reported catheter fracture, material separation issues as a complete circumferential break was noted to the distal end of the catheter attached to the port and a complete circumferential break was noted to the proximal end of the distal catheter segment.The edges of the complete circumferential break on the proximal end of the distal catheter segment were noted to be jagged.However, the investigation is inconclusive for the reported migration issue as the exact circumstances at the time of the reported event cannot be verified.The definitive root cause could not be determined based upon available information.Labeling review: a review of product labeling documentation (e.G., procedural instructions, indications, warnings, precautions, cautions, possible complications, contraindications, nursing guide, and unit label) did not find any product labeling inadequacy.H10: d4 (expiry date: 08/2011).H11: section a through f ¿ the information provide by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Event or Problem Description
It was reported that fifteen years eight months and ten days post port placement, the part of the catheter allegedly fractured and separated.It was further reported that upon x-ray imaging, catheter allegedly migrated to the heart.Reportedly, the remnant fragment was still inside the patient.The current status of the patient is unknown.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TITANIUM DOME IMPLANTABLE PORT, GROSHONG SINGLE-LUMEN, 8F
Common Device Name
PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR
Manufacturer (Section D)
C.R. BARD, INC. (BASD) -3006260740
605 north 5600 west
salt lake city 84116
Manufacturer (Section G)
BARD REYNOSA S.A. DE C.V. -9617592
blvd. montebello #1
parque industrial colonial
reynosa, tamaulipas 88780
MX   88780
Manufacturer Contact
brett curtice
800 w. rio salado pkwy
tempe, AZ 85281
4803032689
MDR Report Key15896491
Report Number3006260740-2022-05560
Device Sequence Number6699569
Product Code LJT
UDI-Device Identifier00801741025754
UDI-Public(01)00801741025754
Combination Product (Y/N)N
Initial Reporter CountryFR
PMA/510(K) Number
K880571
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2007
Device Explanted Year2022
Reporter Type Manufacturer
Report Source Other,Foreign,Health Professional,User Facility,Company Representative
Initial Reporter Occupation Pharmacist
Type of Report Initial,Followup
Report Date (Section B) 03/31/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model Number0602850
Device Catalogue Number0602850
Device Lot NumberREQH0195
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Follow-Up
Initial Date Received by Manufacturer 11/07/2022
Supplement Date Received by Manufacturer03/31/2023
Initial Report FDA Received Date12/01/2022
Supplement Report FDA Received Date04/18/2023
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured08/24/2006
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age67 YR
Patient SexFemale
-
-